|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07F 5/02 | |
| A61K 31/69 | |||
| A61P 31/10 |
| (11) | Number of the document | 1853251 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06735282.3 |
| Date of filing the European patent application | 2006-02-16 | |
| (97) | Date of publication of the European application | 2007-11-14 |
| (45) | Date of publication and mention of the grant of the patent | 2013-04-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2006/005542 |
| Date | 2006-02-16 |
| (87) | Number | WO 2006/089067 |
| Date | 2006-08-24 |
| (30) | Number | Date | Country code |
| 654060 P | 2005-02-16 | US |
| (72) |
BAKER, Stephen, J., US
AKAMA, Tsutomu, US
BELLINGER-KAWAHARA, Carolyn, US
HERNANDEZ, Vincent, S., US
HOLD, Karin, M., US
LEYDEN, James, J., US
MAPLES, Kirk, R., US
PLATTNER, Jacob, J., US
SANDERS, Virginia, US
ZHANG, Yong-Kang, US
FIELDSON, Gregory, US
|
| (73) |
Anacor Pharmaceuticals, Inc.,
1020 East Meadow Circle, Palo Alto, CA 94303,
US
|
| (54) | HALOGEN-SUBSTITUTED BORONOPHTHALIDES FOR THE TREATMENT OF INFECTIONS |
| HALOGEN-SUBSTITUTED BORONOPHTHALIDES FOR THE TREATMENT OF INFECTIONS |